SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-086121
Filing Date
2022-08-04
Accepted
2022-08-04 16:06:30
Documents
14
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2222578d1_8k.htm   iXBRL 8-K 26913
2 EXHIBIT 99.1 tm2222578d1_ex99-1.htm EX-99.1 43196
6 GRAPHIC tm2222578d1_ex99-1img001.jpg GRAPHIC 3728
  Complete submission text file 0001104659-22-086121.txt   257540

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nxtc-20220804.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nxtc-20220804_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nxtc-20220804_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2222578d1_8k_htm.xml XML 3718
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 221136502
SIC: 2834 Pharmaceutical Preparations